✦ LIBER ✦

P178 Cost-effectiveness of switching to exemestane (EX) after 2–3 years of adjuvant tamoxifen (T) in postmenopausal (PM) early breast cancer (EBC)

✍ Scribed by C.G. Pinto; M.S. Castanho; L.S. Miguel; E. Rocha

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Switching to Exeme

✍ David Thompson; Douglas C. A. Taylor; Eduardo L. Montoya; Eric P. Winer; Stephen 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

Cost-effectiveness of exemestane versus

✍ Jonas Lundkvist; Nils Wilking; Stig Holmberg; Linus Jönsson 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 368 KB

Cost-effectiveness of exemestane versus

✍ J. Lundkvist; Wilking; S. Holmberg; M. Lidgren; L. Jönsson 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 123 KB

The effects on lipid serum levels of a 2

✍ A. Montagnani; S. Gonnelli; A. Cadirni; C. Caffarelli; K. Del Santo; C. Pieropan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Carpal tunnel syndrome and musculoskelet

✍ J Sven D Mieog; James P Morden; Judith M Bliss; R Charles Coombes; Cornelis JH v 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 278 KB

Switching of postmenopausal women with e

✍ Raimund Jakesz; Walter Jonat; Michael Gnant; Martina Mittlboeck; Richard Greil; 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 105 KB